Effect of opiate-active substances on pancreatic polypeptide levels in dogs.
D000818:Animals; D002364:Caseins / Q000494:pharmacology*; D004285:Dogs; D004435:Eating; D004723:Endorphins / Q000494:pharmacology*; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology*; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D007700:Kinetics; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology*; D010191:Pancreatic Polypeptide / Q000097:blood*; D013329:Structure-Activity Relationship
D002364:Caseins; D004723:Endorphins; D009270:Naloxone; D004743:Enkephalin, Leucine; D010191:Pancreatic Polypeptide; D016308:Enkephalin, Leucine-2-Alanine; C030279:enkephalinamide-Leu, Ala(2)-; D009020:Morphine; C021968:beta-casomorphins